NRAD Medical Associates, P.C.
Performance
Help| Portfolio Return | 0.00% | 0.00% | 0.00% |
| Comparable Target-Date Fund [why this comparison?] |
0.00% Target-Date 2020 |
0.00% Target-Date 2030 |
0.00% Target-Date 2050 |
| Value-added by Kivalia ($100k starting amount) |
0.0 (0.0%) | 0.0 (0.0%) | 0.0 (0.0%) |
Current Recommendations
(as of 9/30/2020)Help| NAME | TICKER | CONSERVATIVE | MODERATE | AGGRESSIVE |
|---|---|---|---|---|
| Fidelity Contrafund Fund | FCNTX | 8% | 10% | 8% |
| Dreyfus Bond Market Index Fund Class I | DBIRX | 15% | 1% | - |
| Oakmark Equity And Income Fund Class I | OAKBX | 21% | 24% | - |
| PIMCO Total Return Fund Institutional Class | PTTRX | 20% | 11% | - |
| Janus Overseas Fund Class I | JIGFX | 11% | 11% | - |
| Fidelity 500 Index | FXAIX | 25% | 43% | 68% |
| Fidelity Extended Market Index | FSMAX | - | - | 9% |
| Oakmark International Fund Class I | OAKIX | - | - | 7% |
| T. Rowe Price Small-Cap Value Fund | PRSVX | - | - | 8% |
| Total Portfolio | 100% | 100% | 100% |